Results 251 to 260 of about 275,378 (374)
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz +12 more
wiley +1 more source
Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis. [PDF]
Al Ghulaiga FM +5 more
europepmc +1 more source
Internal closure of a posterior perforation using amniotic membrane: A novel surgical technique
Acta Ophthalmologica, EarlyView.
J. S. Suwandi +7 more
wiley +1 more source
Unexpected Fatal Pneumocystis Jirovecii Pneumonia During Triplet Therapy for Hormone-Sensitive Prostate Cancer. [PDF]
Ito F +4 more
europepmc +1 more source
Implementing PEN‐FAST for penicillin allergy delabeling in a high‐prevalence population
Summary Background and objectives Self‐reported penicillin allergies lead to the use of broad‐spectrum antibiotics, increase drug resistance, and constitute an economic burden. The PEN‐FAST score aims to identify low‐risk patients for direct drug provocation tests (DPT) without prior skin testing with a reported negative predictive value (NPV) of over ...
Deniz Göcebe +4 more
wiley +1 more source
Parkinson's disease-associated camptocormia: biopsy-confirmed focal myositis and treatment options. [PDF]
Rosenbohm A +2 more
europepmc +1 more source
F. M. van der Valk +19 more
semanticscholar +1 more source
Summary Background and objectives Systemic sclerosis (SSc) is a rare, chronic autoimmune disease characterized by fibrosis of the skin and/or internal organs. Emerging evidence suggests that subcutaneous adipose tissue may contribute to systemic inflammation and fibrosis in SSc.
Marija Geroldinger‐Simić +3 more
wiley +1 more source
Factors associated with ulcerative colitis with non-anemic iron deficiency. [PDF]
Kitahata S +21 more
europepmc +1 more source
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche +7 more
wiley +1 more source

